Medtronic wins FDA nod for oxygenation device; Bacterin's CEO to resign;

 @FierceMedDev: Seventh Sense revs up crucial trial for microneedle blood collector. More | Follow @FierceMedDev

 @MarkHFierce: The NYT has come out against not just a device tax repeal, but industry lobbying efforts to make their case. Story | Follow @MarkHFierce

 @DamianFierce: AbioMed is studying a next-gen Impella pump targeting FDA approval. Article |& Follow @DamianFierce

> Medtronic ($MDT) snagged FDA clearance for its Affinity Fusion device, a next-generation oxygenation system for cardiac surgery. Release

> Welch Allyn launched a new FlexiPort EcoCuff, a single-patient-use blood pressure cuff the company says can both cut down on hospital-borne contamination and environmental impacts. More

> California's NuvoLase won a CE mark for its PinPointe FootLaser, designed to treat nail fungus. News

> Kimberly-Clark Health Care bought device maker Life Tech's ($LIFE) anesthesia business for an undisclosed amount. Item

> The Korea Food and Drug Administration changed its name to the Ministry of Food and Drug Safety as part of a regulatory reorganization that will affect both device and drug companies doing business there. Blog

> Many multiple sclerosis patients had hoped an implantable balloon treatment for the condition might succeed where drugs have failed, but a rigorous test of the method found no significant benefit. Article

> Bacterin International's president and CEO Guy Cook said he will resign, though he'll stay on in the interim as the board looks for a successor. Story

> SafeStitch Medical raised $3 million in a private placement that will fund development of disposable devices for minimally invasive gastroenterology procedures. Story

Biotech News

 @FierceBiotech: Karolinska portfolio biotech Axelar says PhII lung cancer drug on promising track. More | Follow @FierceBiotech

 @JohnCFierce: Clavis' Olav Hellebo says co. could be sold or shut down, but it's all down to liquidation value now. More | Follow @JohnCFierce

 @RyanMFierce: Immunomedics won an $18M settlement from BoA, now it could use an R&D win with those cancer programs. WSJ Article | Follow @RyanMFierce

> Obama seeks revolutionary brain discoveries on a budget. Story

> Analysis: No quick fix in sight for AstraZeneca's PhIII woes. More

> PolyMedix defaults and hands over a PhII antibiotic to bankruptcy court. News

Pharma News

 @FiercePharma: Lilly works up $180M addition to Indy insulin mfring + $80M in other projects. PR hints at city tax incentives: Release | Follow @FiercePharma

 @EricPFierce: Recalls by Hospira encourage other players to jump into sterile injectable drug manufacturing. More | Follow @EricPFierce

> Merz swoops into Obagi deal with $385M bid, topping Valeant. More

> AZ's Pulmicort patent loss could cost $100M-plus. Story

Biotech Research News

 @EmilyMFierce: Waiting for details today on Obama's $100M brain mapping project. Background here: Story | Follow @EmilyMFierce

> More evidence found for new anti-cancer agent. More

> Diabetes drug slows aging process in worms. Report

> Researchers launch consortium to study neurodegenerative diseases. Item

> Dutch researchers detect early Parkinson's pathology. Article

> New drug could combat resistant malaria strains. More

Pharma Manufacturing News

> Manufacturing issues still dog A.P. Pharma. Story

> Japan's Asada Milling gets warning letter. More

> Lilly doubles down on insulin plant, expands API capacity. Article

> Sanofi adding manufacturing capacity in China, Vietnam. Story

Suggested Articles

U.K.-based surgery robot developer CMR Surgical has begun rolling out its Versius platform to the NHS, completing its first procedures in Europe.

The former Fierce 15 winner’s SuperMap program was cleared to guide electrophysiologists in the treatment of stable and transient arrhythmias.

Insulet announced new agreements with Abbott and Dexcom to connect their continuous glucose monitors with its upcoming tubeless, digital insulin pump,